Owens & Minor (NYSE:OMI) Reaches New 1-Year Low – Time to Sell?

Shares of Owens & Minor, Inc. (NYSE:OMI) hit a new 52-week low during mid-day trading on Monday . The company traded as low as $8.39 and last traded at $8.51, with a volume of 137753 shares traded. The stock had previously closed at $8.65.

Analysts Set New Price Targets

OMI has been the topic of a number of analyst reports. Robert W. Baird lowered their target price on shares of Owens & Minor from $15.00 to $14.00 and set a “neutral” rating on the stock in a report on Tuesday, February 4th. Citigroup decreased their price target on Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a research report on Tuesday, November 5th. Barclays reduced their price objective on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating for the company in a research note on Tuesday, November 5th. Finally, UBS Group lowered their target price on shares of Owens & Minor from $28.00 to $25.00 and set a “buy” rating on the stock in a research note on Tuesday, November 5th. Two analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, Owens & Minor has a consensus rating of “Hold” and a consensus price target of $18.50.

Owens & Minor Stock Performance

The company has a current ratio of 1.09, a quick ratio of 0.45 and a debt-to-equity ratio of 2.11. The firm has a market capitalization of $632.38 million, a P/E ratio of -12.74, a price-to-earnings-growth ratio of 0.25 and a beta of 0.48. The business’s 50 day simple moving average is $13.18 and its two-hundred day simple moving average is $13.99.

Insider Buying and Selling at Owens & Minor

In other Owens & Minor news, CFO Jonathan A. Leon sold 5,282 shares of the stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $11.82, for a total value of $62,433.24. Following the completion of the sale, the chief financial officer now owns 130,822 shares in the company, valued at approximately $1,546,316.04. This represents a 3.88 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 3.59% of the company’s stock.

Institutional Investors Weigh In On Owens & Minor

Institutional investors and hedge funds have recently modified their holdings of the stock. JPMorgan Chase & Co. boosted its holdings in shares of Owens & Minor by 29.6% in the 4th quarter. JPMorgan Chase & Co. now owns 488,497 shares of the company’s stock worth $6,385,000 after purchasing an additional 111,667 shares during the period. Mitsubishi UFJ Trust & Banking Corp grew its holdings in shares of Owens & Minor by 9.8% in the fourth quarter. Mitsubishi UFJ Trust & Banking Corp now owns 306,278 shares of the company’s stock worth $4,003,000 after purchasing an additional 27,295 shares during the last quarter. Vanguard Group Inc. increased its stake in Owens & Minor by 1.2% in the 4th quarter. Vanguard Group Inc. now owns 8,915,756 shares of the company’s stock worth $116,529,000 after buying an additional 107,092 shares during the period. LPL Financial LLC purchased a new stake in Owens & Minor in the 4th quarter valued at about $617,000. Finally, KLP Kapitalforvaltning AS bought a new position in Owens & Minor in the 4th quarter worth about $256,000. Institutional investors own 98.04% of the company’s stock.

About Owens & Minor

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.